Xuzhou Medical University
Clinical trials sponsored by Xuzhou Medical University, explained in plain language.
-
Engineered immune cells take on stubborn leukemia in early trial
Disease control Not yet recruitingThis study tests a new treatment for people with acute myeloid leukemia (AML) that has come back or not responded to standard therapy. The treatment uses the patient's own immune cells, modified to better find and attack leukemia cells. The goal is to see if this therapy can safe…
Phase: PHASE1, PHASE2 • Sponsor: Xuzhou Medical University • Aim: Disease control
Last updated May 26, 2026 12:07 UTC
-
New PET tracer lets doctors watch Cancer-Fighting cells in action
Knowledge-focused Not yet recruitingThis early study tests a new PET tracer that may let doctors see where CAR-T cells go in the body after infusion. Ten adults with multiple myeloma will receive the tracer before their CAR-T therapy. The goal is to track the cells non-invasively and understand how long they last, …
Phase: EARLY_PHASE1 • Sponsor: Xuzhou Medical University • Aim: Knowledge-focused
Last updated May 26, 2026 16:00 UTC